Cipla gets nod from South African and Botswana competition authorities for acquistion of Medpro

20 Jun 2013 Evaluate

Cipla has received approval from the South African and Botswana competition authorities for acquisition of Medpro. However, the implementation of the Scheme is still subject to various other approvals and conditions, including regulatory and government approvals. Earlier on May 15, 2013, the company had received a nod from Shareholders of Cipla Medpro South Africa to acquire 100% stake in the foreign company.

Cipla supplies the bulk of the South African company's drugs through a long-standing agreement; however it has never owned a stake in the Cape Town-based company. This development will give Cipla a direct connect to consumers in South Africa. It also helps the company to integrate its marketing or front-end arm in South Africa with its manufacturing, regulatory and research units.

 

Cipla Share Price

1341.30 15.00 (1.13%)
25-Feb-2026 13:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1759.20
Dr. Reddys Lab 1304.15
Cipla 1341.30
Zydus Lifesciences 915.90
Lupin 2290.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×